| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 56,526,151 | 52,995,781 | ||
| Accounts receivable, net of allowance for credit losses of 191,175 as of september 30, 2025, and 274,300 as of december 31, 2024 | 13,858,292 | 10,922,134 | ||
| Inventory, net | 11,734,822 | 11,200,336 | ||
| Prepaid expenses and other current assets | 1,097,330 | 1,924,955 | ||
| Prepaid income taxes | 1,702,410 | 329,406 | ||
| Total current assets | 84,919,005 | 77,372,612 | ||
| Property and equipment, net | 23,792,441 | 22,938,080 | ||
| Intangible assets, net | 3,373,478 | 3,374,945 | ||
| Deferred tax asset, net | 2,422,481 | 2,557,353 | ||
| Other assets | 214,374 | 204,499 | ||
| Total assets | 114,721,779 | 106,447,489 | ||
| Accounts payable | 2,333,474 | 1,900,980 | ||
| Accrued payroll and benefits | 4,071,176 | 3,210,145 | ||
| Other accrued taxes | 296,207 | 324,644 | ||
| Warranty reserve | 137,025 | 121,221 | ||
| Deferred revenue | 3,158,065 | 3,257,556 | ||
| Accrued income taxes | 2,800,970 | - | ||
| Total current liabilities | 12,796,917 | 8,814,546 | ||
| Deferred revenue, non-current | 3,572,891 | 3,331,557 | ||
| Total liabilities | 16,369,808 | 12,146,103 | ||
| Common stock 0.0001 par value per share 31,500,000 shares authorized 12,721,156 shares issued and outstanding as of september 30, 2025, and 12,709,860 shares issued and outstanding as of december 31, 2024 | 1,272 | 1,272 | ||
| Additional paid-in capital | 32,007,647 | 31,371,123 | ||
| Retained earnings | 66,343,052 | 62,928,991 | ||
| Total stockholders' equity | 98,351,971 | 94,301,386 | ||
| Total liabilities and stockholders' equity | 114,721,779 | 106,447,489 | ||
IRADIMED CORP (IRMD)
IRADIMED CORP (IRMD)